The ethics and regulation of cell and tissue therapies in the UK

Published on August 31, 2015   44 min
0:00
MARK LOWDELL: Hello, I'm Mark Lowdell. I'm the Director of Cell Therapy here at the Royal Free Hospital & UCL Medical School. And today I'm going to talk to you about the field of cell and tissue therapies, how they're regulated, and the impact that regulation has on the ethics.
0:15
So I'm a Cell Therapist. I'm not a doctor here that treats cells. I'm a scientist that uses human cells and tissues to make medicines for tissue engineering, regenerative medicine, and treating cancer and immune deficiencies.
0:30
Now these types of medicines are called Advance Therapy Medicinal Products. It's a clumsy term, and it was defined really in the first directive of 2001, 83, the Medicines Directive. And they consist of gene therapies, somatic cell therapies, and tissue engineered products for the purposes of regenerative medicine. Here are some examples: In the lower screen there you can see a decellularized human trachea that we were using to rebuild a trachea in a child. On the right of that there is a bioengineered nose made out of a biocompatible material. On the right hand side, a photograph from a different group using a similar sort of bio materials to produce an ear structure.
Hide

The ethics and regulation of cell and tissue therapies in the UK

Embed in course/own notes